Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

1.

Pretest genetic counseling informs patients with BRCA mutation.

Printz C.

Cancer. 2012 Dec 15;118(24):6017. doi: 10.1002/cncr.27922. No abstract available.

PMID:
23208671
[PubMed - indexed for MEDLINE]
Free Article
2.

Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.

Euhus DM, Smith KC, Robinson L, Stucky A, Olopade OI, Cummings S, Garber JE, Chittenden A, Mills GB, Rieger P, Esserman L, Crawford B, Hughes KS, Roche CA, Ganz PA, Seldon J, Fabian CJ, Klemp J, Tomlinson G.

J Natl Cancer Inst. 2002 Jun 5;94(11):844-51.

PMID:
12048272
[PubMed - indexed for MEDLINE]
Free Article
3.

The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation.

Sermijn E, Goelen G, Teugels E, Kaufman L, Bonduelle M, Neyns B, Poppe B, De Paepe A, De Grève J.

J Med Genet. 2004 Mar;41(3):e23. No abstract available.

PMID:
14985394
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Counseling the at risk patient in the BRCA1 and BRCA2 Era.

Barnes-Kedar IM, Plon SE.

Obstet Gynecol Clin North Am. 2002 Jun;29(2):341-66, vii. Review.

PMID:
12108833
[PubMed - indexed for MEDLINE]
5.

Hereditary breast/ovarian cancer--pitfalls in genetic counseling.

Dagan E, Gershoni-Baruch R.

Clin Genet. 2001 Oct;60(4):310-3.

PMID:
11683778
[PubMed - indexed for MEDLINE]
6.

Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.

Quinn GP, Vadaparampil ST, Bower B, Friedman S, Keefe DL.

Minerva Med. 2009 Oct;100(5):371-83. Review.

PMID:
19910890
[PubMed - indexed for MEDLINE]
7.

Genetic counseling and management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations.

Silva E, Lynch H.

Breast J. 2006 May-Jun;12(3):280-1; author reply 282-4. No abstract available.

PMID:
16684334
[PubMed - indexed for MEDLINE]
8.

Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.

Bonadona V, Sinilnikova OM, Lenoir GM, Lasset C.

J Natl Cancer Inst. 2002 Oct 16;94(20):1582-3; author reply 1583-4. No abstract available.

PMID:
12381714
[PubMed - indexed for MEDLINE]
Free Article
9.

Genetic counselling for hereditary predisposition to ovarian and breast cancer.

Mackay J, Szecsei CM.

Ann Oncol. 2010 Oct;21 Suppl 7:vii334-8. doi: 10.1093/annonc/mdq365. Review.

PMID:
20943638
[PubMed - indexed for MEDLINE]
Free Article
10.

Summaries for patients. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: U.S. Preventive Services Task Force recommendations.

[No authors listed]

Ann Intern Med. 2005 Sep 6;143(5):I47. No abstract available.

PMID:
16144889
[PubMed - indexed for MEDLINE]
11.

Risk modeling in breast cancer.

Euhus D.

Breast J. 2004 Jan-Feb;10 Suppl 1:S10-2.

PMID:
14984482
[PubMed - indexed for MEDLINE]
12.

BRCA1 and BRCA2 cancer risks.

Antoniou AC, Pharoah PD, Easton DF, Evans DG.

J Clin Oncol. 2006 Jul 10;24(20):3312-3; author reply 3313-4. No abstract available.

PMID:
16829658
[PubMed - indexed for MEDLINE]
13.

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.

Wolff TA, Wilson JE.

Am Fam Physician. 2006 Nov 15;74(10):1759-60. Review. No abstract available.

PMID:
17137007
[PubMed - indexed for MEDLINE]
Free Article
14.

Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients.

Landsbergen K, Verhaak C, Kraaimaat F, Hoogerbrugge N.

Fam Cancer. 2005;4(2):115-9.

PMID:
15951961
[PubMed - indexed for MEDLINE]
15.

One risk fits all?

De Bock GH, Mourits MJ, Oosterwijk JC.

J Clin Oncol. 2007 Aug 1;25(22):3383-4; author reply 3384. No abstract available.

PMID:
17664491
[PubMed - indexed for MEDLINE]
16.

JAMA patient page. BRCA genes and breast cancer.

Pluta RM, Golub RM.

JAMA. 2011 Jun 1;305(21):2244. doi: 10.1001/jama.305.21.2244. No abstract available.

PMID:
21632489
[PubMed - indexed for MEDLINE]
17.

Hereditary breast-ovarian cancer: clinical findings and medical management.

Marshall M, Solomon S.

Plast Surg Nurs. 2007 Jul-Sep;27(3):124-7. Review.

PMID:
17901820
[PubMed - indexed for MEDLINE]
18.

Diagnostic criteria for testing for BRCA1 and BRCA2: the experience of the Department of Defense Familial Breast/Ovarian Cancer Research Project.

Fries MH, Holt C, Carpenter I, Carter CL, Daniels J, Flanagan J, Murphy K, Hailey BJ, Martin L, Hume R, Hudson G, Cadman M, Weatherly R, Nunes ME.

Mil Med. 2002 Feb;167(2):99-103.

PMID:
11873550
[PubMed - indexed for MEDLINE]
19.

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

Scheuer L, Kauff N, Robson M, Kelly B, Barakat R, Satagopan J, Ellis N, Hensley M, Boyd J, Borgen P, Norton L, Offit K.

J Clin Oncol. 2002 Mar 1;20(5):1260-8.

PMID:
11870168
[PubMed - indexed for MEDLINE]
20.

BRCA testing: ethics lessons for the new genetics.

Sherwin S.

Clin Invest Med. 2004 Feb;27(1):19-22. No abstract available.

PMID:
15061582
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk